Viewing Study NCT07309432


Ignite Creation Date: 2026-03-26 @ 3:16 PM
Ignite Modification Date: 2026-03-29 @ 11:51 PM
Study NCT ID: NCT07309432
Status: RECRUITING
Last Update Posted: 2026-02-10
First Post: 2025-12-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Bet v1 Antibodies Effect on Eye Allergy Symptoms in Adolescents and Adults With Birch Pollen Allergy
Sponsor: Regeneron Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module